Skip to main content

Innovex International, Inc.

For the period ended Mar 31, 2026. Filed May 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 5, 2026

INVX$25.13+2.9%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheets

(in thousands, except share and par value amounts)March 31,2026December 31,2025
Assets
Current assets
Cash and restricted cash$200,707$203,407
Trade receivables, net of allowance of $16,330 and $19,752 at March 31, 2026 and December 31, 2025, respectively245,633237,774
Contract assets2,8032,705
Inventories252,987248,433
Assets held for sale1,234—
Prepaid expenses and other current assets49,52735,728
Total current assets752,891728,047
Noncurrent assets
Property and equipment, net163,328158,874
Right-of-use assets – operating51,21352,204
Goodwill99,75899,720
Intangibles, net111,980116,230
Deferred tax asset, net98,226102,375
Other long-term assets10,28110,857
Total noncurrent assets534,786540,260
Total assets$1,287,677$1,268,307
Liabilities and stockholders’ equity
Current liabilities
Accounts payable$74,888$60,711
Accrued expenses35,23249,148
Operating lease liabilities12,64312,670
Contract liabilities11,14411,986
Current portion of long-term debt and finance lease obligations6,1706,709
Other current liabilities7,6856,940
Total current liabilities147,762148,164
Noncurrent liabilities
Long-term debt and finance lease obligations18,04218,922
Operating lease liabilities39,34940,986
Deferred income taxes743500
Legal settlement accrual48,803—
Other long-term liabilities2,0732,036
Total noncurrent liabilities109,01062,444
Total liabilities$256,772$210,608
Commitments and contingencies (Note 16)
Stockholders’ equity
Preferred stock: 10,000,000 shares authorized at $0.01 par value (none issued)$—$—
Common stock: $0.01 par value, 200,000,000 shares authorized at March 31, 2026 and December 31, 2025; 68,635,016 and 69,077,237 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively686691
Additional paid-in capital769,905767,650
Accumulated other comprehensive income5,8344,084
Retained earnings254,480285,274
Total stockholders’ equity$1,030,905$1,057,699
Total liabilities and stockholders’ equity$1,287,677$1,268,307
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.